BSD Medical Corporation -- Tacoma/Valley Radiation Oncology Centers Provide New Cancer Treatment in Pacific Northwest With Acquisition of BSD-500 Hyperthermia System
23. April 2009 08:00 ET
|
BSD Medical Corporation
TACOMA, Wash., April 23, 2009 (GLOBE NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) is pleased to announce that the Tacoma/Valley Radiation Oncology Centers in Tacoma, Washington, have become the...
BSD Medical: TV News Coverage Reports On the Use of Hyperthermia to Treat Recurrent Cancers
17. April 2009 08:05 ET
|
BSD Medical Corporation
SALT LAKE CITY, April 17, 2009 (GLOBE NEWSWIRE) -- BSD Medical Corp. (Nasdaq:BSDM) today reported that hyperthermia treatment was highlighted in a television segment that aired on WKYC, Channel 3,...
BSD Medical: Clinical Study Using Hyperthermia Combined With Chemotherapy to Treat Children and Adolescents Shows Promise
15. April 2009 08:00 ET
|
BSD Medical Corporation
SALT LAKE CITY, April 15, 2009 (GLOBE NEWSWIRE) -- BSD Medical Corp. (Nasdaq:BSDM) today reported on clinical data presented by Rudiger Wessalowski, M.D, Associate Professor at the Clinic of Pediatric...
BSD Medical: Evolving Role of Clinical Hyperthermia Reviewed At Society for Thermal Medicine Annual Meeting
14. April 2009 08:05 ET
|
BSD Medical Corporation
SALT LAKE CITY, April 14, 2009 (GLOBE NEWSWIRE) -- BSD Medical Corp. (Nasdaq:BSDM) today reported on a review of the evolving role of hyperthermia titled, "Current Status of Clinical Trials for Cancer...
BSD Medical Names Harold R. Wolcott as New President and Board Member
07. April 2009 18:34 ET
|
BSD Medical Corporation
SALT LAKE CITY, April 7, 2009 (GLOBE NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) today announced that Harold R. Wolcott, an accomplished executive with extensive experience in the medical...
BSD Medical Corporation: Hyperthermia Therapy Contributes to Improved Tumor Control and Survival Rate for Esophageal Cancer Patients
31. März 2009 08:00 ET
|
BSD Medical Corporation
SALT LAKE CITY, March 31, 2009 (GLOBE NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) today announced that a report titled "Preoperative chemoradiation combined with regional hyperthermia for...
BSD Medical Corp.: Paul F. Turner Receives 2009 Distinguished Alumnus Award From University of Utah
26. März 2009 08:05 ET
|
BSD Medical Corporation
SALT LAKE CITY, March 26, 2009 (GLOBE NEWSWIRE) -- BSD Medical Corp. (Nasdaq:BSDM) is pleased to announce that Paul F. Turner, the company's Chief Technology Officer, Sr. VP and Chairman of the Board,...
BSD Medical Corp.: Lecture At Surgical Oncology Conference Reports Near Doubling of Disease-Free Survival When Hyperthermia Therapy Was Added to Chemotherapy in Treating Sarcoma Cancer Patients
12. März 2009 08:00 ET
|
BSD Medical Corporation
SALT LAKE CITY, March 12, 2009 (GLOBE NEWSWIRE) -- BSD Medical Corp. (Nasdaq:BSDM) announced today that Professor Rolf Issels, M.D. Ph.D. of the Munich University Medical School in Germany delivered...
BSD Files Humanitarian Use Petition With FDA for Marketing Approval for the BSD-2000 Hyperthermia System
05. März 2009 13:03 ET
|
BSD Medical Corporation
SALT LAKE CITY, March 5, 2009 (GLOBE NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) announced today that the company has filed a Humanitarian Use Device Petition for the BSD-2000 Hyperthermia...
BSD Medical Exhibits At 2009 American College of Radiation Oncology Conference
03. März 2009 12:07 ET
|
BSD Medical Corporation
SALT LAKE CITY, March 3, 2009 (GLOBE NEWSWIRE) -- BSD Medical Corp. (Nasdaq:BSDM) today reported on the company's attendance and exhibition at the ACRO (American College of Radiation Oncology) annual...